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Abstract: The evolutionarily conserved target of rapamycin complex 1 (TORC1) couples an array of
intra- and extracellular stimuli to cell growth, proliferation and metabolism, and its deregulation
is associated with various human pathologies such as immunodeficiency, epilepsy, and cancer.
Among the diverse stimuli impinging on TORC1, amino acids represent essential input signals,
but how they control TORC1 has long remained a mystery. The recent discovery of the Rag
GTPases, which assemble as heterodimeric complexes on vacuolar/lysosomal membranes, as central
elements of an amino acid signaling network upstream of TORC1 in yeast, flies, and mammalian
cells represented a breakthrough in this field. Here, we review the architecture of the Rag GTPase
signaling network with a special focus on structural aspects of the Rag GTPases and their regulators
in yeast and highlight both the evolutionary conservation and divergence of the mechanisms that
control Rag GTPases.
Keywords: Rag GTPases; EGO complex; target of rapamycin complex 1 (TORC1); amino acid
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1. Introduction
Eukaryotic cell growth and metabolism are controlled and coordinated by various signaling
pathways that can sense, propagate, and induce responses to environmental signals such as growth
factors, hormones, and nutrients. In this context, a central and particularly well-studied pathway is
the target of rapamycin (TOR) signaling pathway. The TOR proteins are serine/threonine protein
kinases and members of the phosphatidylinositol 3-kinase-related kinase family of proteins that
have been discovered in the budding yeast Saccharomyces cerevisiae due to the isolation of mutations,
which rendered cells resistant to the macrolide rapamycin [1–4]. Parallel studies in mammalian cells
revealed that the TOR proteins are highly conserved among eukaryotes [5–8]. They function in two
structurally distinct protein complexes coined target of rapamycin complex 1 (TORC1) and TORC2
that regulate different aspects of cellular physiology [9,10]. While TORC1 regulates growth and
metabolism through diverse anabolic and catabolic processes including the biosynthesis of proteins,
lipids, and nucleotides, the biogenesis of ribosomes, and autophagy, TORC2 controls cell proliferation,
survival, membrane tension, and turgor as further reviewed elsewhere [11–14]. Interestingly, TORC1,
but not TORC2, is acutely sensitive to rapamycin when in complex with the proline isomerase Fpr1
in yeast (or FKBP12 in mammalian cells) [9], which can be elegantly explained by the fact that
the rapamycin-Fpr1/FKBP12-binding domain in TORC2 is masked by a TORC2-specific protein
subunit [15]. The semi-redundant budding yeast Tor1 and Tor2 proteins (mTOR in mammals), Kog1
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(regulatory-associated protein of TOR (Raptor) in mammals), and Lst8 (mammalian synthetic lethal
with SEC13 protein 8 (mLST8)) form the essential core components of TORC1 [9,16–18].
TORC1 is controlled by different growth-related signals, among which amino acids represent
primeval cues that are sufficient to activate TORC1 in unicellular organisms such as budding yeast.
In multicellular organisms, however, amino acids control TORC1 in parallel to and coordinately
with growth factor and hormonal signals. The latter impinge on TORC1 mainly via the Tuberous
Sclerosis Complex (TSC), a GTPase activating protein (GAP) complex for the small GTPase Rheb that
functions as an essential TORC1 activator in mammals [19–23]. How amino acids regulate TORC1,
in contrast, has long remained a mystery. The recent discovery of the Rag GTPases as central elements
of an amino acid signaling cascade that impinges on TORC1 in yeast, flies, and mammalian cells,
however, represented a breakthrough in this field. This has led to the elucidation of an intriguingly
refined system that enables cells to sample the presence of diverse amino acids and fine-tune TORC1
accordingly. Here, we review the respective knowledge of the Rag GTPase signaling network in
budding yeast with a special focus on structural aspects of the Rag GTPases and their regulators and
a discussion of the evolutionary conservation and divergence of the currently known mechanisms that
control Rag GTPases.
2. The Rag GTPase Module
Gtr1 and Gtr2 define the Rag family of Ras-related GTP-binding proteins in S. cerevisiae and RagA,
RagB, RagC, and RagD the one in higher eukaryotes [24,25]. Human RagA is orthologous to Gtr1
(48% identity; 75% similarity) and paralogous to RagB (90% identity with 33 additional residues in
the N-terminus of RagB). Human RagC is orthologous to Gtr2 (46% identity; 76% similarity) and
paralogous to RagD (81% identity with most of the variability lying in the N- and C-terminal regions
of both proteins) [25–27]. Rag GTPases exhibit all sequence elements that are typically found in
GTPases, such as the P-loop (aka PM1) and the switch regions I (SW I; aka PM2) and II (SW II;
aka PM3), which are known to mediate phosphate and magnesium binding in GTPases of the Ras
family of proteins [25,27,28]. They also contain the guanine base-binding motifs G2 and G3, which,
however, diverge from the ones in Ras family proteins due to the presence of a histidine instead of
an asparagine in G2 and an isoleucine instead of an alanine residue in G3 (Figure 1a) [24,25,27,29].
These differences in the G2 and G3 motifs originally served to distinguish the Rag GTPases as a separate
family of proteins [24,27]. Additional idiosyncratic traits of Rag GTPases include their largely extended
C-terminal domains (CTDs) and their lack of lipid modification motifs that typically serve to anchor
Ras family proteins to membranes (Figure 1b) [25,30]. Interestingly, their extended C-termini function
in the assembly of heterodimeric Rag GTPase complexes that contain Gtr1 and Gtr2, or RagA or
RagB combined with RagC or RagD [25,26]. Amino-acid availability promotes a TORC1-activating
Rag GTPase module configuration in which Gtr1 or RagA/B is GTP-loaded and Gtr2 or RagC/D is
GDP-loaded. Conversely, amino-acid starvation favors the opposite GTP/GDP-loading status within
the respective heterodimers, which then inhibit TORC1 [31–36]. This setting is unique among GTPases,
which are typically active when loaded with GTP and inactive when loaded with GDP [37]. Rag
GTPases associate with the Ego1/Meh1–Ego2–Ego3/Slm4 ternary complex (EGO-TC) in yeast or the
Ragulator complex in mammals (see below), both of which are predominantly and constitutively
anchored within vacuolar or lysosomal membranes, respectively [31,38,39]. In mammalian cells,
the active Rag GTPase module recruits TORC1 (via Raptor) to the lysosome where it interacts, in
a microspherule protein 1 (MCRS1)-sustained manner [40], with GTP-bound Rheb that stimulates
TORC1 through a mechanism that is incompletely understood [34,35,38]. Following amino acid
deprivation, in contrast, Rag GTPase heterodimers favor the release of TORC1 from lysosomal
membranes due to both their diminished affinity towards TORC1 and their recruitment of TSC
that favors the conversion of RhebGTP to RhebGDP [32,41]. Like in mammalian cells, Gtr1GTP–Gtr2GDP
heterodimers, but not the Gtr1GDP–Gtr2GTP ones, interact with and activate TORC1 in yeast [31].
However, yeast TORC1 co-localizes with Rag GTPases at the vacuolar membrane and within
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perivacuolar foci even in the absence of amino acids (or nitrogen) [31,36,42]. Thus, active budding yeast
Rag GTPases are not strictly required to tether TORC1 to membranes, although it appears that they may
influence the relative distribution of TORC1 between vacuolar membranes and perivacuolar foci under
some conditions [43]. Because there is no evidence that suggests a role for the Rheb-orthologous yeast
Rhb1 in controlling TORC1, it remains currently unknown how Rag GTPases activate (or inactivate)
TORC1 in budding yeast.
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Figure 1. (a) Alignment of the G domain sequences of budding yeast (Gtr1 and Gtr2) and human 
(RagA, RagB, RagC, and RagD) Rag GTPases together with the G domain of human Ras (H-Ras). 
Conserved residues are highlighted in grey. Boxes denote typical GTPase sequence motifs (see text). 
Arrow heads mark important residues discussed in the text. Red arrow heads highlight typical Rag 
GTPase residues; (b) Schematic representation of the sequences of yeast and human Rag GTPases 
together with H-Ras. The sequences were aligned with respect to their G domains. 
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typically do so via their G domains [45–48]. The CTDs of Gtr1 and Gtr2 are structurally very similar 
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The heterodimer formation is mediated by hydrogen bonds and hydrophobic interactions mainly 
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the α8 helix of Gtr2 interacts with the α8 helix and four β strands of Gtr1 [26]. Interestingly, the 
conserved leucine 207 (Leu207) residue located within the β7 strand of both CTDs is of central 
importance for Rag GTPase dimerization. In line with this notion, substitution of this residue in Gtr1 
or Gtr2 with a proline is sufficient to abolish the capacity of Rag GTPases to form heterodimers and 
to properly assemble with the EGO-TC subunits Ego1 and Ego3 [29]. When expressed within cells, 
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2.1. Structure and Function of the C-Terminal Domains of Gtr1 and Gtr2
The structures of mammalian Rag GTPases have not been resolved to date. However, given the
high sequence similarities between Gtr1, RagA, and RagB, as well as the ones between Gtr2, RagC,
and RagD [25,26], and the fact that functionally critical residues have been evolutionarily conserved
between yeast and mammalian Rag GTPases (Table 1), Gtr1 and Gtr2 represent bona fide models
to study structural and functional aspects of this family of proteins. In this context, the structures
of two different forms of the Gtr1–Gtr2 complex (i.e., Gtr1GTP–Gtr2GTP and Gtr1GTP–Gtr2GDP) have
recently been resolved (Figure 2a). Accordingly, both Gtr1 and Gtr2 are part of a complex that adopts
a pseudo-twofold symmetry [26,44]. For each subunit two physical domains can be defined: the
N-terminal GTPase domain (or G domain) that is responsible for guanine nucleotide-binding and
the CTD. The two GTPases dimerize through their CTDs while their G domains are not involved in
heterodimer formation [26]. As a result, the dimer interface is distant from the nucleotide-binding
pocket, which defines a new architecture that has not yet been described in any other structure of known
GTPases (Figure 2a). Of note, other GTPases that have also been described to dimerize typically do so
via their G domains [45–48]. The CTDs of Gtr1 and Gtr2 are structurally very similar and characterized
by a central five-stranded anti-parallel β-sheet with a 2-1-4-5-3 topology, surrounded by one long helix
on the side of the G domain, and two helices on the opposite side [26]. The heterodimer formation is
mediated by hydrogen bonds and hydrophobic interactions mainly involving the α8 helix of Gtr1 that
interacts with the α8 helix and two β strands of Gtr2. Conversely, the α8 helix of Gtr2 interacts with
the α8 helix and four β strands of Gtr1 [26]. Interestingly, the conserved leucine 207 (Leu207) residue
located within the β7 strand of both CTDs is of central importance for Rag GTPase dimerization. In
line with this notion, substitution of this residue in Gtr1 or Gtr2 with a proline is sufficient to abolish
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the capacity of Rag GTPases to form heterodimers and to properly assemble with the EGO-TC subunits
Ego1 and Ego3 [29]. When expressed within cells, both the Gtr1L207P and Gtr2L207P alleles also cause
rapamycin sensitivity, which indicates that Rag GTPase heterodimerization and assembly with the
EGO-TC is necessary for proper TORC1 regulation in vivo [29]. In addition to mediating dimerization,
the Gtr2-CTD further contributes to an inter-domain interaction and stabilization of the G domain
specifically in Gtr2GDP by placing the isoleucine 214 (Ile214) into a hydrophobic pocket that is created
by the α6 and α1 helices of the respective G domain [44].
Table 1. Important residues in Rag GTPases.
Protein Residue Function Orthologous Site in RagA/RagB
Gtr1 S15 Possibly impairs GTP hydrolysis S16/S49
Gtr1 S20 Mg2+ coordination T21/T54
Gtr1 L38 Does not favor GTP hydrolysis L39/L72
Gtr1 Q65 Stabilizes the transition state Q66/Q127
Gtr1 L207 Dimerization L205/L266
Protein Residue Function Orthologous Site in RagC/RagD
Gtr2 R18 Stabilizes the transition state R70/R71
Gtr2 S23 Mg2+ coordination S75/S76
Gtr2 T44 Mg2+ coordination T96/T97
Gtr2 E62 Mg2+ coordination D116/D117
Gtr2 Q66 Stabilizes the transition state Q120/Q121
Gtr2 L207 Dimerization L261/L262
Gtr2 I214 G domain stabilization L268/L269
Protein Residue(s) Function Orthologous Site(s) in Gtr1
RagA R24/S25/N30/Y31 Interaction with Raptor R23/S24/N29/Y30
RagA R34/D35/R37/R38 Interaction with Raptor -/D34/R36/R37
RagA H47/H49/R51 Interaction with Raptor H46/H48/R50
RagA N55/V57/N59/W61 Interaction with Raptor N54/-/N58/W60
RagA K230 Ubiquitinated, regulates interaction with GATOR1 K245
RagA K244 Ubiquitinated, regulates interaction with GATOR1 K259
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2.2. Structure and Function of the Gtr1 G Domain 
The G domains of Gtr1 and Gtr2 are structurally and functionally much more divergent than 
their CTDs [26,44]. The G domain in Gtr1GTP is, similarly to other Ras-related GTPases, composed of 
six α helices, six β strands, two switch regions that interact with the γ-phosphate of GTP via hydrogen 
bonds, and a Mg2+ ion in the nucleotide-binding site [44] (Figure 2b). Biochemical experiments have 
demonstrated that Gtr1, like Rag A, exhibits an extremely low intrinsic GTP hydrolysis rate when 
compared to that of other small GTPases like Giα1 or Ras [27,49,50], which may be explained by at 
least two structural differences. Firstly, Gtr1, like members of the Arf GTPase family, is missing an 
important tyrosine (Tyr) in the switch I region that is otherwise conserved in Ras, Rho, and Ran 
Figure 2. (a) Cartoon representation of the structure of the heterodimeric Gtr1–Gtr2 complex ([26],
PDB entry 3R7W); (b) Details of the G domains of Gtr1 and Gtr2. The red regions correspond to the
P-loop and the SW I/SW II domains in each protein. Important residues discussed in the text or listed
in Table 1 are labeled. The Mg2+ atom is shown as a black sphere.
2.2. Structure and Function of the Gtr1 G Domain
The G domains of Gtr1 and Gtr2 are structurally and functionally much more divergent than their
CTDs [26,44]. The G domain in Gtr1GTP is, similarly to other Ras-related GTPases, composed of six
α helices, six β strands, two switch regions that interact with the γ-phosphate of GTP via hydrogen
bonds, and a Mg2+ ion in the nucleotide-binding site [44] (Figure 2b). Biochemical experiments have
demonstrated that Gtr1, like Rag A, exhibits an extremely low intrinsic GTP hydrolysis rate when
compared to that of other small GTPases like Giα1 or Ras [27,49,50], which may be explained by
at least two structural differences. Firstly, Gtr1, like members of the Arf GTPase family, is missing
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an important tyrosine (Tyr) in the switch I region that is otherwise conserved in Ras, Rho, and Ran
GTPases [44]. The respective Tyr32 in Ras plays an important role in stabilizing, via its hydroxyl
group, the transition state of the GTP to GDP hydrolysis reaction, which is why mutation of Tyr32 to
phenylalanine (Phe) decreases the GTP hydrolysis rate of Ras more than 2-fold [51]. The corresponding
leucine (Leu) residue in Gtr1 (i.e., Leu38), however, cannot favor GTP hydrolysis as it makes no contact
with GTP [44]. Secondly, the serine 15 (Ser15) in the P-loop of Gtr1 forms a hydrogen bond with the
γ-phosphate of GTP, which is not the case for most members of the Ras subfamily that have a glycine
(Gly) at the respective position [44]. Ser15 is likely to cause a stereochemical constraint that disfavors
GTP hydrolysis by Gtr1. This is supported by the findings that mutation of the equivalent serine
(Ser31) in Rab3A increases its GTPase activity [52], while mutation of the respective Gly residue in Ras
(Gly12) to Ser creates an oncogenic allele with reduced GTPase activity [53]. Thus, in vivo, Gtr1 is likely
predominantly bound to GTP unless its GTP hydrolytic activity is stimulated by a GAP (see below).
Based on a comparison with mutant alleles of Ras, glutamine 65 (Gln65) in the switch II region
of Gtr1 has also been proposed to be key for GTP hydrolysis [24]. The corresponding residue in
Ras (Gln61) plays a role in stabilizing, together with Tyr32, the transition state of the GTP hydrolysis
reaction. Mutation of this residue compromises the GTP hydrolytic activity of Ras, which renders the
respective “GTP-locked” Ras alleles oncogenic [51,53]. Similarly, expression of a Gtr1Gln65Leu allele also
causes TORC1 hyperactivation and prevents TORC1 inactivation that is mediated by overexpression of
the Gtr1 GAP Iml1 (see below) in vivo [31,54]. Together with the observations that the GTP hydrolytic
activity of Gtr1 (when combined with Gtr2Gln66Leu), but not that of Gtr1Gln65Leu (when combined
with Gtr2), can be stimulated by Iml1 [55], these data indicate that the Gtr1Gln65Leu allele is indeed
predominantly locked in its GTP-bound form as expected.
Yet another comparison with Ras suggests that mutation of serine 20 (Ser20) in the P-loop of Gtr1
may yield a Gtr1 protein that is constitutively inactive [24]. The corresponding serine 17 (Ser17) in
Ras assists in the coordination of the Mg2+ ion that is important for nucleotide binding, and mutation
of Ser17 in Ras can strongly decrease its affinity for nucleotides (particularly strongly for GTP). This
causes the mutated Ras (e.g., RasSer17Ala or RasSer17Asp) to be either nucleotide-free or preferentially
GDP-loaded within cells and to function as dominant negative variants of Ras [56–58]. In line with the
expectation that mutation of Ser20 in Gtr1 may similarly affect its biophysical properties, expression of
a corresponding Gtr1Ser20Leu allele strongly inhibits growth and acts as a semi-dominant inhibitor of
TORC1 in cells [31].
2.3. Structure and Function of the Gtr2 G Domain
Structural data with both crystals, namely Gtr1GTP-Gtr2GTP and Gtr1GTP-Gtr2GDP, revealed that
Gtr2GTP adopts a similar fold to Gtr1GTP (see above), but significantly changes its conformation when
bound to GDP [26,44]. Accordingly, the most dramatic conformational changes take place within the
switch I and II regions, which rearrange in a way that Gtr2GDP is composed of only five α helices and
five β strands and cannot appropriately coordinate the Mg2+ ion in its nucleotide-binding pocket [44].
Because Mg2+ mediates many interactions within the pockets of GTPases, its absence is predicted
to dramatically increase the GDP dissociation rate [59,60]. This structural feature of Gtr2 therefore
explains why it has a relatively low affinity for GDP [44,61], which is also the case for RagC that binds
predominantly GTP and releases GDP swiftly [25]. Notably, because GTP is generally much more
abundant than GDP within cells [62,63], it is, therefore, possible that Gtr2 (and RagC/D) may not
necessarily depend on GTP exchange factors (GEFs) for being reloaded with GTP.
Another distinct feature of the G domain of Gtr2 is that it has, like RagC/D, an arginine in position
18 (Arg18) within its P-loop. This residue corresponds to Ser15 in Gtr1, which likely hampers GTP
hydrolysis by Gtr1 (see above). The structure of Gtr2GMPPNP shows that Arg18 in Gtr2 is close to the
γ phosphate of GMPPNP and, in contrast to Ser15 in Gtr1, likely stabilizes the transition state of the
hydrolysis reaction [44]. An analogous Arg residue is also present in the switch I region of Gtα where
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it stabilizes the transition state of the hydrolysis reaction [64]. This specific Arg at position 18 could
therefore confer some low intrinsic GTPase activity to Gtr2, as it was observed in Rag C [25,44].
Like Gln65 and Ser20 in Gtr1, the corresponding Gln66 and Ser23 residues in Gtr2 are also predicted
to be important for GTPase activity and GTP binding, respectively. Mutations of the corresponding
residues in Gtr2, however, are expected to have the opposite effect on TORC1 in vivo when compared
to the ones in Gtr1. This is indeed the case for Gtr2Gln66Leu, the expression of which inhibits TORC1
and consequently also growth [31]. Expression of the Gtr2Ser23Leu allele, on the other hand, does
not significantly activate TORC1. This may relate to the finding that Gtr2Ser23Leu stimulates the GTP
hydrolysis by Gtr1 in vitro, which could translate into lower levels of active Gtr1GTP in vivo [54]. In
support of this model, expression of Gtr2Ser23Leu can significantly activate TORC1 in the presence of
an active Gtr1Gln65Leu allele or in the absence of the Gtr1 GAP Iml1 [31,54].
2.4. The Gtr1–Gtr2 Module and its Interactions with TORC1
During the hydrolysis of GTP to GDP on Gtr2, the Gtr2 G domain rotates by ≈28◦ and the
one of Gtr1 by ≈6◦, each relative to their C domains, thereby forming a new interaction surface
between the G domains of Gtr1 and Gtr2 [44] (Figure 3). In this configuration, the newly formed
contact between the domains does not change the conformation of the G domain in Gtr1GTP. Notably,
however, the structural similarities between Gtr1 and Gtr2 predict that Gtr1 can also undergo a similar
conformational change to Gtr2 upon GTP-to-GDP conversion. It will therefore be interesting to
address whether the nucleotide-binding state of one G domain may indirectly influence the one of
the other (e.g., by imposing steric constraints that dictate the association/dissociation or hydrolysis
of the nucleotide within the other protein). The dynamic structural changes that come along with
binding and hydrolysis of GTP within the Gtr1–Gtr2 module likely modulate their interactions with
effector proteins such as TORC1. As outlined above, it is the active form of this heterodimer in both
yeast (i.e., Gtr1GTP–Gtr2GDP) and mammals (i.e., RagAGTP/BGTP–RagCGDP/DGDP) that preferentially
interacts with the TORC1 subunit Kog1 (and Tco89) or Raptor, respectively [26,29,31,35,36,43,65].
Because the regions that are predicted to undergo the most dramatic structural changes upon GTP
hydrolysis within the G domain of Gtr1 also correspond to the ones that have been mapped in RagA/B
to interact with Raptor [26] (Table 1), it is likely that GTP hydrolysis and the ensuing G domain
rotation in Gtr1/RagA/B conceals a binding surface for TORC1. In this context, it is also worth
noting that, deduced from the Gtr1GTP–Gtr2GDP crystal structure, the TORC1-interacting surface of
RagAGTP/RagBGTP would form a continuous surface with RagCGDP/RagDGDP, which could elegantly
explain why both RagB and RagC contribute to the binding of Raptor, with the latter having a key role
depending on its nucleotide binding status [35,65].
Biomolecules 2017, 7, 48  6 of 20 
Lik  Gl 65 and S r20 in Gtr1, the corresponding Gln66 and Ser23 residues in Gtr2 re also predicted 
to be important for GTPase activity and GTP binding, respectively. Mutatio s of the corresponding 
residues in Gtr2, however, are expected to have the opposite effect on TORC1 in vivo when compared 
to the ones in Gtr1. This is indeed the case for Gtr2Gln66Leu, the expression of which inhibits TORC1 
and cons quently also growth [31]. Expr ssion of the Gtr2Ser23Leu all le,  the other hand, does not 
significantly activate TORC1. This may relate t  the finding that Gtr2Ser23Leu stimulates the GTP 
hydrolysis by Gtr1 in vitro, which could translate into lower levels of active Gtr1GTP in vivo [54]. In 
supp rt of this model, expression of Gtr2Ser23Leu can significantly activate TORC1 in the presence of a  
active Gtr1Gln65Leu all le or in the absence of the Gtr1 GAP Iml1 [31,54]. 
2.4. The Gtr1–Gtr2 Module and its Interactions with TORC1 
During the hydrolysis of GTP to GDP on Gtr2, the Gtr2 G domain rotates by ≈28° and the one of 
Gtr1 by ≈6°, each relative to their C d mains, thereby forming a new interaction surface between  
G domains of Gtr1 and Gtr2 [44] (Figure 3). In this configuration, the newly formed contact between 
the domains does not change the confo mation of th  G domain in Gtr1GTP. Notably, howeve , the 
structural similarities between Gtr1 and Gtr2 predict hat G r1 can also undergo a similar 
c nforma ional change to Gtr2 upon GTP-to-GDP conve sion. It will therefore be interesting to 
address whether the nucleotide-binding sta e of one G domai  may indirectly influ nce the one of 
the other (e.g., by imposing steric constrain s that dictate the association/dissociation or hydrolysis 
of the nucleotide within the other pro ein). T e dynamic structural changes that come along with 
binding and hydrolysis of GTP within the Gtr1–Gtr2 module likely modulate t eir interactions  
effector proteins such as TORC1. As outlined above, it is th  active form of this heterodimer in bo  
yeas  (i.e., Gtr1GTP–Gtr2GDP) and mammals (i.e., RagAGTP/BGTP–RagCGDP/DGDP) that pref re tially 
interacts wi h the TORC1 subunit Kog1 (and Tco89) or Raptor, respectively [26,29,31,35,36,43,65]. 
Because the regions that are predicted to u erg  the most dramatic structural changes upon GTP 
hydrolysis with n the G domain of Gtr1 also cor espond to the ones that have been m pp d in RagA/B 
to interact ith Raptor [26] (Table 1), it is lik ly that GTP hydrolysis and the ensuing G domain 
r tation in Gtr1/ agA/B conceals a binding surface for TORC1. In thi  contex , it is also worth noting 
that, deduced from the Gtr1GTP–Gtr2GDP crystal structure, the TORC1-i racting surface of 
RagAGTP/RagBGTP would form a continuous surface with RagCGDP/RagDGDP, which ould elegantly 
explain why both RagB and RagC contrib te to th  binding of Raptor, with the latter having a ke  
role depending on its nucleotide binding sta us [35,65]. 
 
Figure 3. Schematic representation of the vacuolar membrane-bound budding yeast Ego1–Ego2–Ego3 
ternary complex (EGO-TC), and of the conformational change of the EGO-TC-associated Gtr1–Gtr2 
heterodimer following the exchange of GDP for GTP on Gtr1 and GTP hydrolysis by Gtr2 (upper 
arrow) and vice versa (lower arrow). 
  
Figure 3. Sche atic representation of the vacuolar e brane-bound budding yeast Ego1–Ego2–Ego3
ternary co plex (E -T ), and of the confor ational change of the E -T -associated tr1– tr2
heterodi er following the exchange of GDP for GTP on Gtr1 and GTP hydrolysis by Gtr2 (upper arrow)
and vice versa (lower arrow).
Biomolecules 2017, 7, 48 7 of 21
3. Regulators of Rag GTPases
Rag GTPases mediate amino acid signals towards TORC1 and their GTP/GDP-loading status is
a critical determinant in this process. Research in this field has therefore more recently focused on the
identification of the regulators of the nucleotide-binding state of Rag GTPases (such as GAPs and GEFs)
and on the elucidation of the sensory mechanisms that mediate amino acid signals to these regulators
(Figure 4). The following sections provide a brief overview of the recent advances in these endeavors.
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[67]. Although the sequence similarity between any of the different subunits within EGO-TC and 
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on the upper side compared with group I proteins) [39,68]. Due to its N-terminal myristoylation and 
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3.1. The EGO-TC and Mammalian Ragulator
Unlike other small GTPases such as Ras, Gtr1 and Gtr2 are not modified by lipid moieties
that could mediate their anchoring to membranes. The Gtr1–Gtr2 module, however, is recruited
to the vacuole via its binding to a ternary complex (coined EGO-TC), which consists of Ego1,
Ego2, and Ego3 [31,33,39,66]. All five proteins (Gtr1, Gtr2, Ego1, Ego2, and Ego3) form the
EGO complex (EGOC), the name of which originated from a screen for mutants that exhibited
a defect in exit from rapamycin-induced growth arrest [66]. Similar to EGO-TC, mammalian Rag
GTPases are tethered to lysosomes by a protein complex coined Ragulator [38]. This complex is
composed of five different proteins: lysosomal adaptor and mitogen-activated protein kinase and
mTOR Ragulator 1 (LAMTOR1)/p18, LAMTOR2/p14, LAMTOR3/MP1, LAMTOR4/C7orf59, and
LAMTOR5/HBXIP [67]. Although the sequence similarity between any of the different subunits within
EGO-TC and Ragulator is low, structural comparisons indicate that EGO-TC is likely the equivalent of
Ragulator [39]. For instance, Ego2/3 and LAMTOR2-5 all contain a roadblock domain, which is defined
by an α-β-α sandwich with the central β-sheet flanked by one α-helix on the bottom and one or two
α-helices on the upper side. Due to differences in the amount of the flanking α-helices, EGO-TC and
Ragulator subunits can be subdivided into two different groups containing either Ego2, LAMTOR4,
and LAMTOR5 (group I) or Ego3, LAMTOR2, and LAMTOR3 (group II; with an additional α-helix
on the upper side compared with group I proteins) [39,68]. Due to its N-terminal myristoylation
and palmitoylation [69,70], Ego1 functions as a tether for the entire EGOC [31] (Figure 3). Similarly,
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LAMTOR1 tethers the Rag GTPase-Ragulator complex to the lysosomal surface via its N-terminal
palmitoyl- and myristoyl-moieties and functions as a scaffold for the other subunits [67,71]. While
the EGO-TC plays primarily a role as a platform that recruits the Gtr1–Gtr2 heterodimer to the
vacuolar membrane [39], the role of Ragulator appears not to be restricted solely to scaffolding the
Rag GTPase to the lysosomal membrane. Instead, Ragulator also functions as a GEF for RagA/B
downstream of the vacuolar H+-ATPase (v-ATPase) [67] (see also below). While there is currently no
data available that suggest a role for EGO-TC as a GEF for Gtr1, this task is exerted by Vam6 (alone
or combined with additional associated proteins) in yeast [31,68,72] (Figure 4a). Vam6 (aka Vps39) is
a component of the homotypic fusion and vacuole protein sorting (HOPS/Class C-Vps) complex that
promotes vacuolar fusion events as an effector of the Rab7 GTPase Ypt7 [73–75]. As such, the HOPS
complex is also required for proper TORC1 signaling [76,77], but Vam6 clearly plays additional HOPS
complex-independent roles. For instance, Vam6 is specifically involved in the establishment of contact
sites between vacuoles and mitochondria to facilitate the lipid transfer between these organelles [78,79].
Vam6 therefore occupies a central stage in coordinating cellular events such as membrane fusion, lipid
exchange, and metabolism with TORC1 activity. Notably, higher eukaryotes express two Vam6-like
proteins, namely hVps39-1 (or hVam6) and hVps39-2 [80–82], of which Vps39-2 is orthologous to
the class C core vacuole/endosome tethering (CORVET) complex subunit Vps3 [83]. Knockdown of
hVps39-1 blocks early-to-late endosome conversion and reduces mTORC1 activity [84]. Nevertheless,
hVps39-1 does not function as a GEF for RagA/B, since it does not stimulate GDP or GTP dissociation
from RagB in vitro and does not bind RagA in vivo [67].
3.2. SEACIT and SEACAT and the Orthologous Mammalian GATOR Complexes
Genetic experiments in yeast identified Npr2 and Npr3 as negative regulators of TORC1 [85].
Both proteins are part of the octameric Seh1-associated protein complex (SEAC) [86], and form,
together with Iml1, the trimeric SEACIT subcomplex (for SEAC inhibiting TORC1) that antagonizes
TORC1 by acting as a GAP module on Gtr1 [54,87]. Interestingly, the remaining five proteins (Seh1,
Sec13, Rtc1/Sea2, Mtc5/Sea3, and Sea4) form another SEAC subcomplex termed SEACAT (for SEAC
activating TORC1) that stimulates TORC1 likely by inhibiting SEACIT via a mechanism that is currently
not understood [87]. SEACIT localizes at the vacuolar membrane where Iml1 transiently stimulates
the GTPase activity of Gtr1 in an Npr2-/Npr3-dependent manner when cells are starved for amino
acids [87] (Figure 4a). How amino acids impinge on SEACIT/SEACAT is currently not known.
However, methionine favors SEACIT disassembly through biosynthesis of S-adenosylmethionine,
which serves as methyl donor for Ppm1-mediated methylation and activation of the catalytic subunit
of the type 2A protein phosphatase (PP2A). The latter dephosphorylates Npr2 to prevent it from
associating with Npr3 and Iml1 [88].
SEACIT and SEACAT have functionally and structurally related orthologs in mammals named
GATOR1 (GAP activity towards Rags; containing DEPDC5, NPRL2, and NPRL3) and GATOR2
(containing Seh1L, Sec13, Wdr24, Wdr59, and Mios), respectively [89,90]. Like their yeast counterparts,
GATOR1 functions as RagA/B GAP to inactivate TORC1 when amino acids are scarce, while GATOR2
likely inhibits GATOR1 when amino acids are present abundantly (Figure 4b, see also below; of note,
the GATOR2 subunit Wdr24 also controls lysosome acidification and autophagic flux independently
of TORC1 in fly and mammalian cells [91]). The recruitment of GATOR1 to the lysosomal surface
and its interaction with Rag GTPases requires the KPTN, ITFG2, C12orf66 and SZT2-containing
regulator of TORC1 (KICSTOR) scaffolding complex, and loss of KICSTOR components (that are not
readily identifiable in yeast) leads to hyperactive TORC1 [92,93]. The GATOR1-RagA association is
additionally regulated by ubiquitination. Amino acid starvation, for instance, stimulates the respective
association by K63-linked ubiquitination of RagA on Lys142, Lys220, Lys230 and Lys244 via the RING
family E3 ligase RNF152. This serves to inactivate RagA and consequently also TORC1 [94]. Similarly,
ubiquitination of Lys15 in RagA by the Skp1/Cullin/F-box E3 ligase complex also promotes the
GATOR1-RagA interaction, although in this case this happens during amino acid refeeding as part
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of a feedback loop that prevents TORC1 hyperactivation [95]. Whether analogous ubiquitination
mechanisms regulate the interaction of SEACIT with Gtr1 in yeast remains to be studied, but at least
Lys230 and Lys244 appear to be conserved in Gtr1 (Table 1).
3.3. The Lst4–Lst7 and Orthologous FNIP1/2–FLCN Complexes
FNIP1 and FNIP2 each combine with Folliculin (FLCN) to form a complex that is required for the
amino acid-mediated recruitment of TORC1 to the lysosome by the Rag GTPases [65,96]. Interestingly,
although the FNIP1/2–FLCN module directly and preferentially binds the TORC1-inactivating
versions of RagA/B in starved cells [65,96,97], it stimulates the GTPase activity of RagC/D and hence
promotes the binding of Raptor with the Rag GTPase heterodimer at the lysosomal membrane [65]
(Figure 4b). It is, therefore, conceivable that the FNIP1/2–FLCN complex remains tethered to the
lysosomal membrane in the absence of amino acids only to be properly placed and ready to stimulate
GTP hydrolysis by RagC/D. FNIP1/2–FLCN thus favors the recruitment of TORC1 to the lysosomal
surface where it can be activated by Rheb, when amino acids become available. Yeast express
a FNIP1/2–FLCN-orthologous complex, namely Lst4–Lst7, that functions as GAP for Gtr2 specifically
when starved cells are refed with amino acids [55] (Figure 4a). Similar to FNIP1/2–FLCN, the Lst4–Lst7
complex also accumulates at the vacuolar membrane in amino acid-starved cells and is dispersed form
this location when cells are refed with amino acids. At variance with the situation in higher eukaryotes,
however, where the FNIP1/2–FLCN heterodimer binds Rag GTPases in starved cells, the Lst4–Lst7
complex binds Rag GTPases weakly in the absence of amino acids, but more strongly in amino acid-fed
or re-fed cells. In addition, rather than binding Gtr1 or GDP-free Gtr1Ser20Leu, the Lst4–Lst7 complex
favors binding GTP-locked Gtr2, which is a trait that is common for GTPases and their cognate
GAPs [55]. Thus, the Lst4–Lst7 complex associates with the vacuolar membrane proximal to, but not
via the Rag GTPases in amino acid starved cells. There, it is able to stimulate the GTPase activity of
Gtr2 upon amino acid refeeding, which results in TORC1 activation and release of Lst4–Lst7 from
the vacuolar membrane. In this context, it will be interesting to explore whether the latter effect is
part of a feedback inhibition loop that may serve to protect TORC1 from hyperactivation upon amino
acid refeeding. Notably, methionine, cysteine, glutamine, as well as asparagine and aspartate that can
be deaminated and converted to glutamate/glutamine [98], are all specifically efficient in displacing
the Lst4–Lst7 complex from the vacuolar membrane. How these amino acids are sensed and how the
respective sensory mechanisms impinge on Lst4–Lst7 are therefore key questions to be addressed in
the near future.
4. Amino Acids and Their Sensors Upstream of the Rag GTPases
Despite the fact that wild-type budding yeasts are prototrophic, i.e., can synthesize all amino acids
on their own, they can sense the presence of any extracellular amino acid and mediate the respective
signal to activate TORC1 within minutes, although with different amplitudes [99]. The underlying
common or specific sensory mechanism(s) are currently, in most cases, still elusive. Similarly, it is
not known whether all of the respective signals regulate TORC1 via the Rag GTPases, but many
(e.g., methionine, cysteine, glutamine, asparagine, and aspartate) clearly do so [55,88,99,100]. In this
context, it is worth noting that yeast cells can also use virtually any amino acid as nitrogen source,
but the different amino acids vary greatly with respect to their capacity to sustain vigorous growth.
Accordingly, yeasts preferentially grow on high quality nitrogen sources such as arginine, asparagine,
and glutamine, while they grow for instance very poorly on the branched-chain amino acids leucine,
isoleucine, and valine [98]. Importantly, the quality of the amino acid as a nitrogen source, or its
metabolic input value, is also coupled to TORC1, albeit via Rag GTPase-independent mechanisms that
ultimately define the relative growth rate of cells. Thus, any given amino acid potentially contributes
in qualitatively, quantitatively, temporally, and mechanistically distinct ways to TORC1 regulation.
Adding to this complexity, some amino acids have become essential (e.g., branched-chain amino acids)
or conditionally essential (e.g., arginine and glutamine) in higher eukaryotes including humans, which
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may have favored the evolution of specific amino acid-sensory system that needed to be newly wired
to TORC1. In the following, we provide a brief overview on our current knowledge of specific amino
acids that have recently been discovered to be coupled to the control of the Rag GTPase-TORC1 branch.
4.1. Leucine
The branched-chain amino acid leucine is the most frequently encoded amino acid in eukaryotic
genomes [101]. It is, therefore, not surprising that leucine also activates TORC1 [102]. Two studies
have provided insight into how the levels of leucine, or of branched-chain amino acids, are sensed
and transmitted to Rag GTPases. Accordingly, a classical co-IP approach pinpointed the leucyl-tRNA
synthetase (LeuRS) Cdc60 as a leucine-dependent, Gtr1-interacting protein [103]. LeuRS is both
necessary and sufficient to mediate leucine signaling to Gtr1 and this positive input is disrupted by
the engagement of LeuRS in editing mischarged tRNALeu, which is likely a consequence of leucine
limitation. In the presence of leucine, however, LeuRS interacts with and promotes the GTP-loading
status of Gtr1, likely by protecting Gtr1 from a GAP and/or by assisting a positive regulator (Figure 4a).
LeuRS therefore senses the balanced levels of branched-chain amino acids via the fidelity of tRNALeu
aminoacylation and signals this information via an incompletely understood mechanism to the Rag
GTPases. This also fits well with the finding that branched-chain aminotransferases, which interconvert
leucine α-ketoisocaproate and leucine, act upstream of the LeuRS-EGOC-TORC1 signaling module,
although they also control TORC1 in parallel by controlling the flux through the tricarboxylic acid
(TCA) cycle via their interaction with the key TCA-cycle enzyme Aco1 [100]. Strikingly, mammalian
LeuRS has also been found to control TORC1, both by Rag GTPase-dependent and -independent
mechanisms [104,105]. The former requires LeuRS itself to function as a RagD GAP when leucine is
present [104] (Figure 4b), even though this was not recapitulated in an independent study [65].
Leucine has recently also been discovered to feed into the Rag GTPase network via a group of
paralogous proteins coined Sestrins [106–110]. Intriguingly, Sestrin2 directly binds leucine and a crystal
structure could be obtained that reveals both a leucine-binding pocket and a highly conserved GATOR2
binding site [111]. Moreover, Sestrin2 (and to a lesser extent Sestrin1 and 3) interacts with GATOR2
predominantly during amino acid deprivation to inhibit TORC1 indirectly via GATOR1 [106–108]
(Figure 4b). It is, therefore, conceivable that Sestrin2 antagonizes GATOR2 when it is not bound to
leucine and that leucine-binding triggers a conformational change in Sestrin2 that masks its GATOR2
binding site [111]. However, whether Sestrin2 indeed undergoes such a conformational change
is currently a matter of debate as it appears that the leucine-free apo-structure of Sestrin2 is still
elusive [112–114]. Notably, one study also suggested that Sestrins regulate Rag GTPases more directly
by acting as GDP dissociation inhibitors (GDIs) of RagA/B, which would inactivate the Rag GTPase
heterodimer and consequently TORC1 under amino acid-starvation conditions [109]. Thus, Sestrin2
may do both, act directly and indirectly (via GATOR2) on Rag GTPases. However, because the GDI
motif is buried within the structure of the leucine-bound form of Sestrin2, this would require Sestrin2
to adopt a different conformation in the absence of leucine such that the respective motif would be
exposed at the surface of the protein [111]. Finally, Sestrins are also stress-inducible proteins that inhibit
TORC1 through the AMP-activated protein kinase (AMPK) and the TSC complex even under amino
acid-replete conditions [114,115]. It appears therefore that Sestrins, which are not readily identifiable
in yeast, have evolved to control TORC1 via multiple different mechanisms.
4.2. Glutamine
Glutamine is of central importance for supplying carbon and nitrogen atoms for biosynthetic
reactions (e.g., biosynthesis of amino acids, nucleotides, and the primary cellular antioxidant
glutathione) and for replenishing the TCA cycle, hence providing the bioenergy to drive cellular
growth (for a review see [116]). Current knowledge indicates that glutamine regulates TORC1 via
both Rag GTPase-dependent and -independent ways, although the mechanistic details remain poorly
understood in each case. In mammals for instance, glutaminolysis, i.e., the sequential deamination of
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glutamine by glutaminase (GLS) and glutamate dehydrogenase (GDH), stimulates α-ketoglutarate
production and consequently activation of the Rag GTPase-TORC1 branch through an incompletely
resolved mechanism that implicates the prolyl-hydroxylase PHD [117]. Of note, leucine also contributes
in this framework to glutamine-mediated TORC1 activation by acting as a co-factor for GDH [117–119].
Conversely, glutamine contributes to leucine-mediated TORC1 activation by acting as an anti-solute to
import leucine into the cytoplasm via the SLC7A5–SLC3A2 heterodimeric antiporter [120], which also
plays a role upstream of TORC1 by modulating the distribution of glutamine and leucine between the
lysosome and the cytoplasm [121]. Glutamine activates TORC1 also independently of the Rag GTPases
in both yeast and mammalian cells [99,122]. In mammalian cells, this requires the ADP-ribosylation
factor 1 (Arf1) and the v-ATPase [122]. Whether yeast may also employ Arf1 to control TORC1 is not
known, but recent evidence indicates that the vacuolar membrane-associated phosphatidylinositol
3-phosphate binding protein Pib2 acts together with a Vps34–Vps15 phosphatidylinositol 3-kinase
complex to mediate glutamine signals to TORC1 in parallel to EGOC [123–125].
4.3. Arginine
How yeast TORC1 integrates arginine signals is presently unknown. In higher eukaryotes,
however, arginine activates TORC1 through at least two different mechanisms. The first one involves
the lysosomal membrane-localized amino acid transporter SLC38A9, which communicates (likely
lysosomal) arginine levels to the Rag GTPases to control TORC1 [126–128]. SLC38A9 associates with
both Ragulator and the Rag GTPases in an amino-acid dependent manner and loss of SLC38A9
compromises arginine-induced TORC1 activation. The second mechanism relies on the cytosolic
arginine sensor CASTOR1 that forms homo- or heterodimers (with CASTOR2), which, like Sestrin2,
bind and inhibit GATOR2 in the absence of arginine [129]. Arginine binding disengages CASTOR
dimers from binding GATOR2, which may thereby become competent to inhibit GATOR1 and
consequently stimulate TORC1 (Figure 4b). Structural analyses of homodimeric CASTOR1 revealed
that this mechanism relies on arginine binding between two (of four) ACT (for aspartate kinase,
chorismate mutase, and TyrA) domains, which likely triggers a conformational change that conceals
an adjacent binding surface for GATOR2 (or more specifically for its subunit Mios) [130–132].
Interestingly, although yeast cells do not express CASTOR proteins [12], CASTOR1 may have evolved
from the regulatory domain of ancestral aspartate kinases including Hom3 in yeast [130]. Together
with the finding that loss of Hom3 renders cells sensitive to rapamycin and exhibits negative genetic
interactions with loss of SEACAT (i.e., Seh1, Sec13, and Mtc5/Sea3) and EGOC (i.e., Ego1 and Ego3)
subunits [133,134], this warrants further analyses that address the possibility that Hom3 may also
mediate amino acid signals to TORC1 via the Rag GTPases.
4.4. The V-ATPase and Vacuolar/Lysosomal-Membrane Resident Amino Acid Permeases
The amino acid-sensitive branch of TORC1 signaling localizes at the vacuolar/lysosomal
periphery where it is ideally placed to integrate both cytosolic and vacuolar/lysosomal amino acid
pools. Because amino acids (and other metabolites) shuttle across the vacuolar/lysosomal membrane
through amino acid permeases that function either as H+-antiporter (in) or H+-symporter (out) [98,135],
their distribution between the two compartments is largely driven by the proton gradient across the
respective membrane. The latter is established through the vacuolar/lysosomal H+-ATPase (v-ATPase),
a proton-pump that hydrolyses ATP to import protons into the vacuolar/lysosomal lumen [136,137].
The v-ATPase therefore plays a key role in controlling TORC1 both indirectly via its effect on the
subcellular distribution of amino acids, but also through its role in pH homeostasis [138,139]. Moreover,
in flies and mammals, the v-ATPase also directly interacts with the Ragulator-Rag GTPase complex
to promote the GEF activity of Ragulator toward RagA/B in response to intra-lysosomal amino
acids [67,140] (Figure 4b). How and which amino acids signal through the v-ATPase remains, however,
still elusive. In yeast, the v-ATPase also acts upstream of the Rag GTPases, but it controls TORC1
in response to the pH in the cytoplasm, which serves as a proxy for the quality and quantity of the
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available carbon source [141]. Whether the yeast v-ATPase-Rag GTPase module is implicated in
signaling vacuolar amino acid levels has not yet been reported.
In addition to SLC38A9, other lysosome-based amino acid permeases have also been found to
control TORC1. For instance, the proton and amino acid symporter PAT1/SLC36A1, which shuttles
small unbranched amino acids across the lysosomal membrane, is required for mTORC1 activation by
amino acids and interacts with RagC/D [142,143]. Similarly, SLC15A4 is a lysosomal proton-coupled
histidine transporter, which mediates TORC1 activation during the inflammatory response [144].
Although it remains unclear whether SLC15A4 regulates TORC1 via the Rag GTPases, these studies
indicate that the Rag GTPase-TORC1 branch may be poised to integrate information on specific amino
acids in part by interrogating a diverse array of vacuolar/lysosomal amino acid permeases in parallel.
Because yeast cells express vacuolar membrane-resident amino acid permeases that are structurally
and functionally similar to SLC38A9, PAT1/SLC36A1, and SCL15A4 [98], it will be interesting to
evaluate whether the emerging concept of amino acid permeases as transceptors that signal amino
acid levels to Rag GTPases/TORC1 is of ancestral origin.
5. Additional Signals and Modulators that Impinge on Rag GTPases
Besides their role in mediating amino acid signals, the Rag GTPases have also been found to
transmit information on other nutrient cues. The mammalian v-ATPase-Ragulator complex, for
instance, recruits AXIN, which inhibits the GEF activity of Ragulator and activates AMPK through
LKB1 when cells are starved for glucose [145]. Interestingly, expression of constitutively active
RagAGTP prevents TORC1 inactivation under similar conditions [146], which indicates that the Rag
GTPases mediate also glucose sufficiency in higher eukaryotes. In yeast, glucose starvation also
results in TORC1 downregulation, but the role of the Rag GTPases in this process appears less
influential [147,148]. In addition to glucose, cholesterol has also recently been found to activate the
Rag GTPase-TORC1 branch via the arginine sensor/transporter SLC38A9, which binds lysosomal
cholesterol through a conserved cholesterol-binding motif within its transmembrane helix 8 and
mediates the respective signal in a manner that is independent of its arginine-sensing mechanism [149].
In parallel, SLC38A9 also binds the Nieman-Pick C1 (NPC1) protein that antagonizes TORC1 activation
by shuttling cholesterol back into the cytoplasm.
In addition to their regulation by classical means (that is by GAPs and GEFs), Rag GTPases
have also been found to be controlled by a number of different modulators specifically in higher
eukaryotes. For instance, the MAP4K3 protein kinase positively regulates TORC1 and physically
interacts with and likely acts upstream of RagA and Rag C [150–152]. In addition, p62 binds to and
promotes the active form of the Rag GTPases to form a docking platform for TORC1 at the lysosomal
membrane in response to amino acids [153]. A similar positive role in Rag GTPase-TORC1 control
is exerted by the Nudix-type motif 2 (NUDT2) protein [154]. The SH3 domain-binding protein 4
(SH3BP4), in contrast, binds TORC1-inactivating Rag GTPases to inhibit their conversion into the
TORC1-activating form and consequently antagonizes the recruitment of TORC1 to the lysosome [155].
Finally, c17orf59 modulates TORC1 activity by interacting with Ragulator and disrupting the Rag
GTPase-Ragulator interaction [156]. Whether any of these additional regulatory modules represent
ancestral modes of Rag GTPase control is currently not known. Lastly, we would like to point out that
several recent studies also indicated the existence of pathways by which amino acids regulate TORC1
independently of Rag GTPases. Although the respective mechanisms are not integral elements of the
Rag GTPase signaling network, we would like to refer the reader here to the corresponding primary
literature [122,157–160].
6. Final Remarks
The basic architecture of the Rag GTPase-TORC1 signaling network is remarkably conserved
within the eukaryotic kingdom [161–163], and mutations in individual components of this network are
associated with various human pathologies such as immunodeficiency, epilepsy, and cancer [12,164].
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Understanding the molecular details by which the Rag GTPases integrate amino acid and other signals
in various model systems ranging from yeast, over flies to mammalian cells is therefore indispensable
for the establishment of therapies against diseases that are causally related to deregulated TORC1.
Pertinent issues that remain to be addressed in this rapidly expanding field of Rag GTPase-centered
research are manifold. For instance, structural analyses of the Rag GTPases combined with the
pentameric Ragulator, which are currently not available, would help understand how Ragulator
associates with and exerts, unlike the functionally orthologous EGO-TC in yeast, GEF activity towards
Rag GTPases. Similarly, structural analyses regarding the association of the Rag GTPases with TORC1,
the structure of which has also been solved recently [165–168], are likely to yield a more precise
comprehension of the molecular details through which Rag GTPases activate and/or inactivate
TORC1. Finally, structural studies of the Rag GTPases combined with their cognate GAPs (i.e.,
SEACIT/GATOR1 with Gtr1/RagA/B and Lst4–Lst7/FNIP1/2–FLCN with Gtr2/RagB/C) would
provide valuable information on the basic mechanisms through which these GAPs stimulate GTP
hydrolysis by Rag GTPases. In parallel to all of these structural studies, further biochemical studies
(which may perhaps be suitably studied using nuclear magnetic resonance spectroscopy) may address
the question whether the Rag GTPases themselves can impact on each other to mutually modulate
their GTP/GDP-loading status. Moreover, and beyond these structural/functional issues regarding
the core of the Rag GTPase module, it still remains to be queried how exactly the currently known
amino acid sensors such as the LeuRS, the lysosomal amino acid permeases, the v-ATPase, and the
Sestrin/CASTOR proteins transmit their information to the Rag GTPases. In this context, it appears
equally important to decipher how the different signals are gauged and integrated by the Rag GTPases
both in qualitative and quantitative terms. Last, but not least, it will be interesting to appropriately
define the ancestral Rag GTPase network design to be able to appreciate those mechanisms that
have specifically been grafted onto the Rag GTPase module through evolution. Although recent
research has dramatically broadened our view on how amino acids impinge on TORC1, this brief,
non-comprehensive outline of unsolved questions illustrates that this fascinating field of research still
holds many secrets that remain to be unveiled.
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